Healthcare Social
Networking
Is the Australian pharma industry
ready to join the conversation?
Len Starnes
Head of Digital...
‘We are living
in the middle
of the largest
increase in
expressive capability in the
history of the human race’
Clay Shirk...
Two formidable
hurdles…many latent
opportunities
Pharma abhors a
regulatory vacuum
Adapted from: Web 2.0 in Healthcare, John Sharp, Cleveland Clinic, USA
Risk averse
Authoritative sources
Privacy & securit...
Social
networking
Public relations
Consumers
& patients
Non-traditional
HC partners
Knowledge
sharing &
collaboration
Phys...
Physicians
Next decade
Predominance
of e-savvy
physicians
Routine use of
SNs by majority
of physicians
Dwindling of
sales forces
Pred...
Physicians’
social networks
Ubiquitous
Transformational
The power to transform
the exchange of medical
information
Pharmaceutical
industry
Peer-to-peer dialogue
Medical
profession
2010200920082007
Growth in physicians’
social networks
Today
> 70 networks
> 3m members
Membership
1m
2m
3m
2011
115,000
members
each
180k members
Pan-European
network 2011
First authenticated
global network
34k members
214 countries
www.dxy.cn
Largest network
in China
1,700,000 members
16%
Using +
very interested
53%
Somewhat
interested
31%
Not interested
+ do not know
Majority of Australian doctors
using ...
1843
1528
656 622
1558
0
1000
2000
USA Australia India Ireland Malaysia
Registered
users
Nov 2010
Australian doctors
2nd l...
Australia’s 1st
true doctors’
social network
Content +
community
Launched
September
2400
Members*
www.e-healthspace.com.au
Strategic partnering options
Observation Research Engagement
Unmet needs
Treatment trends
Drug usage monitoring
Early iden...
Physicians want
Source: Joel Selzer, Ozmosis, February 2010
Fast, simple, reliable answers
to product questions
Peer-to-pe...
R&D
Clinical
research
‘Patients are
the invisible
stakeholders’
ePatient Dave
BlogWorld
October 2010
Patients are talking to
one another, learning from
one another, making
treatment recommendations
and…
sharing quantitative...
The data-driven community
Patients share
structured
information about
their disease to
help themselves
and others
Quantifi...
Insights on drug usage
in the real world
3016
patients
1029 patient
evaluations
Status 8.11.10
‘In future the
less private
you are, the
longer you’ll live’
Jamie Heywood
Co-founder &
Chairman
PatientsLikeMe
New industry partnerships
forming to capture real-world
experiences
‘…the community will generate
patient-reported outcome...
Demonstrable
high-level vision
‘…will shape the
way we do our work,
and ultimately help
improve transplant
patient outcome...
ALS Star trial
Parkinson’s community
Clinical trails awareness
PLM exemplifies a new breed
of non-traditional
healthcare p...
PR
Image:
eDrug Research.com
Mistrust between
industry and consumers
Broken trust between industry
and the medical profession
Ethos of the industry is
...
Trust is crucial for survival
‘We need to foster trust between
pharma and academic and
scientific communities so that we
c...
JnJ is showing how to build trust again
Marc Monseau is the human
face of J&J on the internet…
…and a
social
media
evangelist
Empowered to blog and get
JnJ back into ‘The Conversation’
Empowered
to engage in
‘what’s happening
now’ conversations
Empowered
to engage
the blogging
health
community
Other pharmas are committing
to more transparency
Recognizing
the ubiquity &
benefits of SM
Urging staff
to become
SM scou...
Pharma will become more…
Lkn: www.linkedin.com/in/lenstarnes
Twt: www.twitter.com/lenstarnes
Ssh: www.slideshare.net/lenstarnes
Opinions expressed ...
Upcoming SlideShare
Loading in...5
×

Healthcare Social Networking: Is the Australian Pharma Industry Ready to Join the Conversation?

2,615

Published on

Presentation first given 25th November 2010 as an introduction to a pharma social media workshop at iStrategy Sydney.

1 Comment
4 Likes
Statistics
Notes
  • Great Presentation, Len.
    I remember the experiment of J&J as one of the first blogging experience in the world pharma Marketing scenario.
    It was olny few years ago but it is like a century.
    Thing are evolving so rapidly that pharma stakeholders do not understand nor opportunities and threats of being involved in the process.
    Most companies are not communicating with customers and prospect and they do not comprehend that there is not other way than the web 2.0 approach.
    Meedical doctors are less inhibited than pharma companies, but there is a real fear to meet with patients online.
    Some doctors are ready to talk and share with collegues but this is not enough.
    Web 2.0 is made of interactions and is is possible that different kinds of interanctions could be moderated.
    I don't know what's up in Australia but they seems to be smart enough to fligh high. :-)
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total Views
2,615
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
164
Comments
1
Likes
4
Embeds 0
No embeds

No notes for slide
  • Why should not use SM:
    - Adverse events
    - Off-label usage
    - Fair balance
    Accountability for UGC
    -etc, etc
    Why should use SM:
    - More compelling perhaps???
  • Being copied and adapted globally
  • Data sold to pharmas, huge market researchpotential
    Biz model on which PLM is based
  • -
  • Others
    - Daily Strength- Healthy Place
  • Ray Kerin, Head of PR Pfizer, 2009, interview with industry commentator John Mack
    Thought lomg and hard whether to include this topic
    Interest of openness and transparency thought would be best
  • - Key question: How do we build trust again?- Industry must get back in to the convesation
    But not by simply sending out the same messahe via SM
    - Must really engage, open up, talk
    Other indsuries do, but have an easier time
  • - One crucial area where trust is crucial = R&D
  • Know Marc very well
    Not marketeer, scientist, medic, or lawyer
    Excellent communicator
    - Degree in English-Industry needs more communicators that stakeholders can trust
  • 4500 followers
  • Roche. Another great example for industry
    Recently published SM Principles on web
    SM Guidance for staff
    Discussed what it meams and how the Principles were developed at Digipharm conference 2 weeks ago.
  • Don‘t yet know what openness will ultimately look like
    - All working on it- Can only be a good thing
  • Healthcare Social Networking: Is the Australian Pharma Industry Ready to Join the Conversation?

    1. 1. Healthcare Social Networking Is the Australian pharma industry ready to join the conversation? Len Starnes Head of Digital Marketing & Sales General Medicine iStrategy Sydney Sydney 24 – 25 November 2010 Len Starnes Bayer Schering Pharma
    2. 2. ‘We are living in the middle of the largest increase in expressive capability in the history of the human race’ Clay Shirkey, Here Comes Everybody, 2008
    3. 3. Two formidable hurdles…many latent opportunities
    4. 4. Pharma abhors a regulatory vacuum
    5. 5. Adapted from: Web 2.0 in Healthcare, John Sharp, Cleveland Clinic, USA Risk averse Authoritative sources Privacy & security regulated Long lead times Controlled access to data & information IP Risk taking Crowd wisdom Open to all Rapid deployment Anyone may contribute/distribute Open source A clash of cultures
    6. 6. Social networking Public relations Consumers & patients Non-traditional HC partners Knowledge sharing & collaboration Physicians High-impact zones R&D & Clinical Governance & organization
    7. 7. Physicians
    8. 8. Next decade Predominance of e-savvy physicians Routine use of SNs by majority of physicians Dwindling of sales forces Predominance of multi-channel engagement models More physicians expecting e-self service from pharma More physicians willing to engage with pharma on SNs
    9. 9. Physicians’ social networks Ubiquitous Transformational
    10. 10. The power to transform the exchange of medical information Pharmaceutical industry Peer-to-peer dialogue Medical profession
    11. 11. 2010200920082007 Growth in physicians’ social networks Today > 70 networks > 3m members Membership 1m 2m 3m 2011
    12. 12. 115,000 members each
    13. 13. 180k members Pan-European network 2011 First authenticated global network 34k members 214 countries
    14. 14. www.dxy.cn Largest network in China 1,700,000 members
    15. 15. 16% Using + very interested 53% Somewhat interested 31% Not interested + do not know Majority of Australian doctors using or interested in HCPs’ social networks Taking the Pulse Asia v09, Manhattan Research 2008 - 2009
    16. 16. 1843 1528 656 622 1558 0 1000 2000 USA Australia India Ireland Malaysia Registered users Nov 2010 Australian doctors 2nd largest ex-UK user group
    17. 17. Australia’s 1st true doctors’ social network Content + community Launched September 2400 Members* www.e-healthspace.com.au
    18. 18. Strategic partnering options Observation Research Engagement Unmet needs Treatment trends Drug usage monitoring Early identification of critical issues Post questions to a specialist community Conduct surveys Establish panels based on pre-selected criteria Participation by pharma physicians Support speciality communities Post information germane to discussions
    19. 19. Physicians want Source: Joel Selzer, Ozmosis, February 2010 Fast, simple, reliable answers to product questions Peer-to-peer interaction and trusted feedback Customer services but on members’ terms
    20. 20. R&D Clinical research
    21. 21. ‘Patients are the invisible stakeholders’ ePatient Dave BlogWorld October 2010
    22. 22. Patients are talking to one another, learning from one another, making treatment recommendations and… sharing quantitative personal health data
    23. 23. The data-driven community Patients share structured information about their disease to help themselves and others Quantifiable, measurable, actionable
    24. 24. Insights on drug usage in the real world 3016 patients 1029 patient evaluations Status 8.11.10
    25. 25. ‘In future the less private you are, the longer you’ll live’ Jamie Heywood Co-founder & Chairman PatientsLikeMe
    26. 26. New industry partnerships forming to capture real-world experiences ‘…the community will generate patient-reported outcomes that may help UCB better understand how patients live with epilepsy and help advance epilepsy care’ Peter Verdu, VP Clinical Research, UCB, 2009
    27. 27. Demonstrable high-level vision ‘…will shape the way we do our work, and ultimately help improve transplant patient outcomes now and in the future.’ Joe Jiminez Novartis CEO, 2010
    28. 28. ALS Star trial Parkinson’s community Clinical trails awareness PLM exemplifies a new breed of non-traditional healthcare partners
    29. 29. PR Image: eDrug Research.com
    30. 30. Mistrust between industry and consumers Broken trust between industry and the medical profession Ethos of the industry is constantly called into question
    31. 31. Trust is crucial for survival ‘We need to foster trust between pharma and academic and scientific communities so that we can work together to create the innovative breakthroughs that will fulfil unmet needs and benefit patients everywhere’ Paul Stoffels Head of Global R&D, Johnson & Johnson
    32. 32. JnJ is showing how to build trust again
    33. 33. Marc Monseau is the human face of J&J on the internet… …and a social media evangelist
    34. 34. Empowered to blog and get JnJ back into ‘The Conversation’
    35. 35. Empowered to engage in ‘what’s happening now’ conversations
    36. 36. Empowered to engage the blogging health community
    37. 37. Other pharmas are committing to more transparency Recognizing the ubiquity & benefits of SM Urging staff to become SM scouts
    38. 38. Pharma will become more…
    39. 39. Lkn: www.linkedin.com/in/lenstarnes Twt: www.twitter.com/lenstarnes Ssh: www.slideshare.net/lenstarnes Opinions expressed in this presentation are entirely those of the author and do not necessarily reflect those of his employer Len Starnes

    ×